Terumo Co. (OTCMKTS:TRUMY) Sees Significant Decline in Short Interest

Terumo Co. (OTCMKTS:TRUMY) was the recipient of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 700 shares, a drop of 76.7% from the February 29th total of 3,000 shares. Based on an average daily volume of 27,800 shares, the short-interest ratio is currently 0.0 days.

Terumo Stock Up 1.2 %

Shares of OTCMKTS TRUMY opened at $37.36 on Thursday. The company has a quick ratio of 1.13, a current ratio of 1.90 and a debt-to-equity ratio of 0.06. The business’s 50 day moving average is $36.72 and its two-hundred day moving average is $32.26. Terumo has a 52-week low of $25.11 and a 52-week high of $41.19. The firm has a market cap of $27.93 billion, a price-to-earnings ratio of 38.84 and a beta of 0.65.

Terumo (OTCMKTS:TRUMY) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $0.27 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.27. Terumo had a return on equity of 8.26% and a net margin of 11.14%. The firm had revenue of $1.62 billion for the quarter. Research analysts predict that Terumo will post 1.14 EPS for the current year.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.